July 25, 2025 a 03:43 pm

HSIC: Fundamental Ratio Analysis - Henry Schein, Inc.

Henry Schein, Inc. Stock Analysis

Henry Schein, Inc. operates in the healthcare sector, providing essential products and services to a wide range of medical establishments. The company's robust distribution network and innovative technology solutions offer solid growth potential. However, market competition and economic fluctuations present challenges for future performance.

Fundamental Rating

Henry Schein, Inc. currently holds a 'B+' rating in our assessment, reflecting its solid financial standing and potential for growth.

Category Score Visualization
Discounted Cash Flow 4
Return on Equity 4
Return on Assets 4
Debt to Equity 1
Price to Earnings 2
Price to Book 3

Historical Rating

The historical scores reflect the consistency in the company's financial metrics over time.

Date Overall DCF ROE ROA D/E P/E P/B
2025-07-24 3 4 4 4 1 2 3
Previous Date 0 4 4 4 1 2 3

Analysts' Price Targets

Analyst consensus indicates a positive outlook with potential upside to the current stock price based on projected targets.

High Low Median Consensus
$86 $75 $80.5 $80.5
Stock Price Chart of Henry Schein, Inc.

Analysts' Sentiment

The sentiment among analysts is largely favorable, with a majority recommending a "Buy".

Recommendation Count Visualization
Strong Buy 0
Buy 14
Hold 13
Sell 3
Strong Sell 0

In conclusion, Henry Schein, Inc. showcases a solid business model underlined by strong fundamentals and promising analyst projections. While the overall market presents volatility, the company's focus on technological advancements and healthcare distribution could provide resilience against competitive pressures. Yet, investors should be mindful of potential macroeconomic impacts. Overall, the stock represents a balanced risk-reward proposition.